Clinical Research Progress on the Correlation between Thyroid Hormones and Idiopathic Pulmonary Fibrosis
DOI:
https://doi.org/10.54097/hwf92117Keywords:
Thyroid Hormones, Idiopathic Pulmonary Fibrosis, Glucose Metabolism, Mitochondria, Inflammation, Alveolar Epithelial Cells, Fibroblasts, Myofibroblasts, MacrophagesAbstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal interstitial lung disease with unknown etiology, characterized by lung parenchymal scarring and progressive lung function decline, and poor prognosis. Its pathogenesis remains unclear. Recent studies have confirmed a significant correlation between thyroid hormones (THs) and IPF’s occurrence and development. This article systematically reviews relevant clinical research progress: (1) Epidemiological studies show a significantly higher incidence of thyroid dysfunction in IPF patients; (2) Mechanistic studies indicate THs affect IPF progression by regulating glucose metabolism, improving mitochondrial function, inhibiting inflammation, modulating alveolar epithelial repair, and suppressing fibroblast activation; (3) Clinical intervention studies suggest thyroid function management may improve IPF prognosis. These findings provide new insights for IPF diagnosis and treatment, and this article further discusses the potential value of thyroid hormone replacement therapy in IPF management.
Downloads
References
[1] Wuyts W A, Agostini C, Antoniou K M, et al. The pathogenesis of pulmonary fibrosis: a moving target[J]. European Respiratory Journal, 2013,41(5):1207-1218.
[2] Guo X, Xu K, Wang L, et al. Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway[J]. Frontiers in Pharmacology, 2024,15:1433186.
[3] Breitzig M T, Alleyn M D, Lockey R F, et al. Thyroid hormone: a resurgent treatment for an emergent concern[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2018,315(6): L945-L950.
[4] Kim D, Kim W, Joo S K, et al. Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis[J]. Clinical gastroenterology and hepatology, 2018, 16(1): 123-131.e1.
[5] Bano A, Chaker L, Muka T, et al. Thyroid function and the risk of fibrosis of the liver, heart, and lung in humans: a systematic review and meta-analysis[J]. Thyroid, 2020, 30(6): 806-820.
[6] Gao X, Chen Z, Liu M, et al. Effects of short‐term levothyroxine therapy on myocardial injuries in patients with severe overt hypothyroidism: Evidence from a cardiac MRI Study[J]. Journal of Magnetic Resonance Imaging, 2017, 46(3): 897-904.
[7] Wei J F, Yue H M, Liu N Y, et al. Research progress on the correlation between thyroid hormones and idiopathic pulmonary fibrosis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 307.
[8] Boggaram V. Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung[J]. Clinical science, 2009, 116(1): 27-35.
[9] Birring S S, Morgan A J, Prudon B, et al. Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease[J]. Thorax, 2003, 58(6): 533-536.
[10] Rousseau J P, Buteau-Poulin A, Kinkead R. Maternal thyroid hormone deficiency and cardiorespiratory disorder in rat pups[J]. Experimental Neurology, 2019, 320: 112960.
[11] Rousseau J P, Tenorio-Lopes L, Ghio S C, et al. Thyroid hormones during the perinatal period are necessary to respiratory network development of newborn rats[J]. Experimental Neurology, 2021, 345: 113813.
[12] Chaker L, Papaleontiou M. Hypothyroidism: a review[J]. JAMA, 2025.
[13] Oldham J M, Kumar D, Lee C, et al. Thyroid disease is prevalent and predicts survival in patients with idiopathic pulmonary fibrosis[J]. Chest, 2015, 148(3): 692-700.
[14] George J T, Thow J C, Rodger K A, et al. Reversibility of fibrotic appearance of lungs with thyroxine replacement therapy in patients with severe hypothyroidism[J]. Endocrine practice, 2009, 15(7): 720-724.
[15] Yu G, Tzouvelekis A, Wang R, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function[J]. Nature medicine, 2018, 24(1): 39-49.
[16] Morris A. Thyroid hormone therapy resolves pulmonary fibrosis in mice[J]. Nature Reviews Endocrinology, 2018, 14(2): 64-64.
[17] van der Spek A H, Jim K K, Karaczyn A, et al. The thyroid hormone inactivating type 3 deiodinase is essential for optimal neutrophil function: observations from three species[J]. Endocrinology, 2018, 159(2): 826-835.
[18] Barca-Mayo O, Liao X H, DiCosmo C, et al. Role of type 2 deiodinase in response to acute lung injury (ALI) in mice[J]. Proceedings of the National Academy of Sciences, 2011, 108(49): E1321-E1329.
[19] Rangarajan S, Bernard K, Thannickal V J. Mitochondrial dysfunction in pulmonary fibrosis[J]. Annals of the American Thoracic Society, 2017, 14(Supplement 5): S383-S388.
[20] Bueno M, Calyeca J, Rojas M, et al. Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis[J]. Redox biology, 2020, 33: 101509.
[21] Bueno M, Lai Y C, Romero Y, et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis[J]. The Journal of clinical investigation, 2015, 125(2): 521-538.
[22] Mora A L, Bueno M, Rojas M. Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis[J]. The Journal of clinical investigation, 2017, 127(2): 405-414.
[23] Noli L, Khorsandi S E, Pyle A, et al. Effects of thyroid hormone on mitochondria and metabolism of human preimplantation embryos[J]. Stem cells, 2020, 38(3): 369-381.
[24] Singh B K, Sinha R A, Tripathi M, et al. Thyroid hormone receptor and ERRα coordinately regulate mitochondrial fission, mitophagy, biogenesis, and function[J]. Science signaling, 2018, 11(536): eaam5855.
[25] Wrutniak-Cabello C, Casas F, Cabello G. Mitochondrial T3 receptor and targets[J]. Molecular and cellular endocrinology, 2017, 458: 112-120.
[26] Falzacappa C V, Timperi E, Bucci B, et al. T (3) preserves ovarian granulosa cells from chemotherapy-induced apoptosis [J]. Journal of Endocrinology, 2012, 215(2): 281-289.
[27] Lesmana R, Sinha R A, Singh B K, et al. Thyroid hormone stimulation of autophagy is essential for mitochondrial biogenesis and activity in skeletal muscle[J]. Endocrinology, 2016, 157(1): 23-38.
[28] Betensley A, Sharif R, Karamichos D. A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis[J]. Journal of clinical medicine, 2016, 6(1): 2.
[29] Xie N, Tan Z, Banerjee S, et al. Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis[J]. American journal of respiratory and critical care medicine, 2015, 192(12): 1462-1474.
[30] Dias H B, de Oliveira J R, Donadio M V F, et al. Fructose-1, 6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts[J]. PLoS One, 2019, 14(9): e0222202.
[31] Mullur R, Liu Y Y, Brent G A. Thyroid hormone regulation of metabolism[J]. Physiological reviews, 2014, 94(2): 355-382
[32] Brent G A. Mechanisms of thyroid hormone action[J]. The Journal of clinical investigation, 2012, 122(9): 3035-3043.
[33] Peçanha F L M, Dos Santos R S, da-Silva W S. Thyroid states regulate subcellular glucose phosphorylation activity in male mice[J]. Endocrine Connections, 2017, 6(5): 311-322.
[34] Chen J, Zhou Q, Feng J, et al. Activation of AMPK promotes thyroid cancer cell migration through its interaction with PKM2 and β-catenin[J]. Life Sciences, 2019, 239: 116877.
[35] Yang M, Wang D, Gan S, et al. Triiodothyronine ameliorates silica-induced pulmonary inflammation and fibrosis in mice[J]. Science of The Total Environment, 2021, 790: 148041.
[36] Judge J L, Nagel D J, Owens K M, et al. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol[J]. PloS one, 2018, 13(5): e0197936.
[37] Alonso-Merino E, Martin Orozco R, Ruiz-Llorente L, et al. Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses[J]. Proceedings of the National Academy of Sciences, 2016, 113(24): E3451-E3460.
[38] Li L, Nie X, Yi M, et al. Aerosolized thyroid hormone prevents radiation induced lung fibrosis[J]. Frontiers in Oncology, 2020, 10: 528686.
[39] Butler M W, Keane M P. The role of immunity and inflammation in IPF pathogenesis[M]//Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide. Cham: Springer International Publishing, 2018: 97-131.
[40] Cho S J, Moon J S, Nikahira K, et al. GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation[J]. Thorax, 2020, 75(3): 227-236.
[41] Wootton S C, Kim D S, Kondoh Y, et al. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis[J]. American journal of respiratory and critical care medicine, 2011, 183(12): 1698-1702.
[42] Phan T H G, Paliogiannis P, Nasrallah G K, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis[J]. Cellular and Molecular Life Sciences, 2021, 78(5): 2031-2057.
[43] Mercader-Barceló J, Truyols-Vives J, Río C, et al. Insights into the role of bioactive food ingredients and the microbiome in idiopathic pulmonary fibrosis[J]. International Journal of Molecular Sciences, 2020, 21(17): 6051.
[44] Molyneaux P L, Maher T M. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis[J]. European Respiratory Review, 2013, 22(129): 376-381.
[45] Montesinos M M, Pellizas C G. Thyroid hormone action on innate immunity[J]. Frontiers in endocrinology, 2019, 10: 350.
[46] Van der Spek A H, Fliers E, Boelen A. Thyroid hormone and deiodination in innate immune cells[J]. Endocrinology, 2021, 162(1): bqaa200.
[47] Huang Y, Ma S F, Espindola M S, et al. Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis[J]. American journal of respiratory and critical care medicine, 2017, 196(2): 208-219.
[48] Gan S, Yang M, Fan L, et al. Triiodothyronine attenuates silica-induced oxidative stress, inflammation, and apoptosis via thyroid hormone receptor α in differentiated thp-1 macrophages[J]. Chemical Research in Toxicology, 2020, 33(5): 1256-1265.
[49] Contreras-Jurado C, García-Serrano L, Gomez-Ferrería M, et al. The thyroid hormone receptors as modulators of skin proliferation and inflammation[J]. Journal of Biological Chemistry, 2011, 286(27): 24079-24088.
[50] Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline[J]. American journal of respiratory and critical care medicine, 2015, 192(2): e3-e19.
[51] Ucero A C, Bakiri L, Roediger B, et al. Fra-2–expressing macrophages promote lung fibrosis[J]. The Journal of clinical investigation, 2019, 129(8): 3293-3309.
[52] Roth G J, Binder R, Colbatzky F, et al. Nintedanib: from discovery to the clinic[J]. Journal of medicinal chemistry, 2015, 58(3): 1053-1063.
[53] Inomata M, Kamio K, Azuma A, et al. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis[J]. Respiratory research, 2014, 15(1): 16.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
